rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
20
|
pubmed:dateCreated |
2007-6-14
|
pubmed:abstractText |
To evaluate the effect of antiviral agents on intrahepatic HBV DNA in HBeAg-positive chronic hepatitis B patients.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1007-9327
|
pubmed:author |
pubmed-author:ChenXin-YueXY,
pubmed-author:ChenYongY,
pubmed-author:HanZhong-HouZH,
pubmed-author:HouDong-MingDM,
pubmed-author:IvanHadadH,
pubmed-author:LuHai-YingHY,
pubmed-author:MeeSS,
pubmed-author:SiChong-WenCW,
pubmed-author:YuYan-YanYY,
pubmed-author:ZengZhengZ,
pubmed-author:ZhuangLi-WeiLW
|
pubmed:issnType |
Print
|
pubmed:day |
28
|
pubmed:volume |
13
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2878-82
|
pubmed:meshHeading |
pubmed-meshheading:17569128-Adult,
pubmed-meshheading:17569128-Antiviral Agents,
pubmed-meshheading:17569128-DNA, Viral,
pubmed-meshheading:17569128-Drug Therapy, Combination,
pubmed-meshheading:17569128-Female,
pubmed-meshheading:17569128-Genotype,
pubmed-meshheading:17569128-Hepatitis B, Chronic,
pubmed-meshheading:17569128-Hepatitis B e Antigens,
pubmed-meshheading:17569128-Hepatitis B virus,
pubmed-meshheading:17569128-Humans,
pubmed-meshheading:17569128-Interferon-alpha,
pubmed-meshheading:17569128-Lamivudine,
pubmed-meshheading:17569128-Liver,
pubmed-meshheading:17569128-Male,
pubmed-meshheading:17569128-Middle Aged,
pubmed-meshheading:17569128-Predictive Value of Tests,
pubmed-meshheading:17569128-Treatment Outcome,
pubmed-meshheading:17569128-Virus Replication
|
pubmed:year |
2007
|
pubmed:articleTitle |
Intrahepatic HBV DNA as a predictor of antivirus treatment efficacy in HBeAg-positive chronic hepatitis B patients.
|
pubmed:affiliation |
Department of Infectious Diseases, Peking University First Hospital, Beijing 100034, China.
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|